The Global Refurbished DNA Sequencing Platforms Market was
valued at $41 million in 2016 and is expected to reach $112 million in 2023,
registering a CAGR of 15.0% from 2017 to 2023. DNA sequencing is a technology
in which several DNA strands could be sequenced through massive
parallelization. Low cost, high accuracy and speed, and precise results even
from low sample input are the main advantages DNA sequencing offers over
microarray and other genomic analysis methods. Refurbished and used DNA
sequencing platforms are relatively inexpensive instruments used for DNA
sequencing, when compared with new DNA sequencing platforms.
The key players operating in the global
refurbished DNA sequencing market include Illumina, Inc., Thermo Fisher
Scientific, Inc., Beckman Coulter (Fullerton, CA), and 454 Life Sciences
Corporation (Roche Holding AG).and LI-COR
Request for
Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/4594
Key Benefits
- The study provides an in-depth analysis
of the refurbished global DNA sequencing market, with current trends and
future estimations to elucidate the imminent investment pockets.
- A quantitative analysis from 2017 to 2023
to enable the stakeholders to capitalize on the prevailing market
opportunities is discussed.
- Key market players are profiled and their
strategies are analyzed thoroughly, which help understand the competitive
outlook of the market.
- Porters Five Forces model interprets the
bargaining power of suppliers & buyers, threat of new entrants &
substitutes, and competition in the key players.
Refurbished DNA Sequencing
Platforms Market Key Segments:
By Region
- U.S.
- Rest of the world
No comments:
Post a Comment